Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-128575
Filing Date
2016-06-17
Accepted
2016-06-17 16:21:12
Documents
1
Period of Report
2016-06-16

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3978
  Complete submission text file 0001209191-16-128575.txt   5364
Mailing Address CLEARVIEW PROJECTS ONE PALMER SQUARE, SUITE 436 PRINCETON NJ 08542
Business Address
WEG KENNETH E (Reporting) CIK: 0001192596 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36167 | Film No.: 161720372

Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Issuer) CIK: 0001503802 (see all company filings)

EIN.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations